Rejected at 2:02 a.m. Nov, 01, 2023 ] by Ahmed7
Author: vellistar
Related Note: 1509669339317 1
Rationale for change

updated in uworld 2023 version---for the extra section, valbenazine should be listed along with deutatrabenazine as both are approved vmat2 inhibitors by the FDA. it's in uworld and i can send a screenshot if you would like. and the uworld table in the note is also out of date in this card. i put deutetrabenazine in the edit.

Rejection reason

please include QID

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Empty field
OME
Additional Resources
One by one
Empty field
#PANCE::EOR::PSYCH #AK_Step2_v12::!Shelf::#Cards_AnKing_Skipped #AK_Step2_v12::#OME_banner #AK_Step2_v12::Original_decks::Dorian::psych::uw #AK_Step2_v12::#B&B::13_Psych::04_Psychopharmacology::02_Antipsychotics::Extra #AK_Step2_v12::#UWorld::COMLEX::103200 #AK_Step2_v12::#AMBOSS::C8aqKm #AK_Step2_v12::#Resources_by_rotation::Psych::uworld::zanki #AK_Step3_v12::#UWorld::12828 #PANCE::BEHAVIORAL::bipolar #AK_Other::!AK_UpdateTags::AnKing_Image::AhmedA::Extrapyramidal_Symptoms #AK_Step2_v12::#Resources_by_rotation::Psych::uworld::dorian #AK_Step2_v12::#AMBOSS::4ea3_j #AK_Step2_v12::Original_decks::Zanki_Step_2::Psych::UW_Psych #AK_Step1_v12::#AMBOSS::4ea3_j #AK_Other::#AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step2_v12::#UWorld::Step::16066 #AK_Step2_v12::!Shelf::Psych #AK_Step2_v12::#UWorld::Step::2518 #AK_Other::!AK_UpdateTags::AnKing_Image::MS::Extrapyramidal_symptoms #AK_Other::!AK_UpdateTags::AnKing_Image::Mujeeb::Extrapyramidal_symptoms #AK_Step2_v12::#Subjects::Psychiatry::07_Psychotic_Disorders::*Antipsychotics::*Extrapyramidal_Side_Effects::Tardive_Dyskinesia #PANCE::BEHAVIORAL::schizophrenia #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Psychiatry::Extrapyramidal_symptoms #AK_Step2_v12::#UWorld::COMLEX::28332